Grape seed extract—a dietary supplement made from the seeds of wine grapes—has been investigated to see if it can help reduce ...

Scott Tagawa, MD, highlights the PSMAddition trial's promising results, showcasing Lutetium-177 PSMA-617's significant ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...

Adding the drug enzalutamide to standard hormone therapy reduced deaths by more than 40% in men with recurrent prostate ...

WEDNESDAY, Oct. 22, 2025 (HealthDay News) — A powerful new drug combo has yielded a major breakthrough for men battling an ...

Prostate cancer relies on genetic "switches", called enhancers, that can turn on tumor-promoting genes.

A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...

A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

On-treatment PSA and disease burden should be considered together for prognostication. Achieving PSA ≤0.2 ng/mL within 6–12 weeks strongly predicts favorable long-term survival. Metastatic volume and ...

Some prostate cancer patients are “missing out” on vital, life-saving treatment, a charity has warned. Thirty-one per cent of men in England with aggressive but curable prostate cancer are missing out ...

Although the Endocrine Society guidelines recommend TRT for men with testosterone levels ≤ 300 ng/dL in two morning samples, a primary concern is its potential to exacerbate prostate-related ...